Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis

Project Information

CancerFingerPrints

Grant agreement ID: 838414

DOI 10.3030/838414

Project closed

EC signature date 12 March 2019

Start date 1 May 2019

End date 31 October 2020

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 150 000,00

EU contribution € 150 000,00

Coordinated by

UNIVERSITY OF CYPRUS
Cyprus

Publications

Peer reviewed articles (1)

TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity

Author(s): Myrofora Panagi, Chrysovalantis Voutouri, Fotios Mpekris, Panagiotis Papageorgis, Margaret R Martin, John D Martin, Philippos Demetriou, Chryso Pierides, Christiana Polydorou, Andreas Stylianou, Maria Louca, Laura Koumas, Paul Costeas, Kazunori Kataoka, Horacio Cabral, Triantafyllos Stylianopoulos
Published in: Theranostics, Issue 10/4, 2020, Page(s) 1910-1922, ISSN 1838-7640
Publisher: Ivyspring International Publisher
DOI: 10.7150/thno.36936